Observational studyFrontiers in immunology2023

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis.

Alessandro Maglione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.